DIA Biosimilars 2013

Awards & Advancement

Worldwide Clinical Trials receives strong CRO ratings from ISR

Friday, April 20, 2012 02:16 PM

Worldwide Clinical Trials (WCT), a global, full-service CRO, has received strong ratings and recommendations from Industry Standard Research (ISR), who recently published “2012 CRO Quality Benchmarking Report.”

More... »

Cenduit: Now with Patient Reminders

CRA wins ViE award for best clinical trial site network

Wednesday, April 18, 2012 01:02 PM

Tempe, Ariz.-based Clinical Research Advantage (CRA), a community-based network of clinical trial sites, has been named best clinical trial site network bythe World Vaccine Congress.

More... »

CRF Health – eCOA Forum

Quintiles named best CRO in vaccine excellence awards

Friday, April 13, 2012 02:01 PM

Quintiles, a global biopharmaceutical services company, has been named “Best Clinical Research Organization” (CRO) in the Vaccine Industry Excellence (ViE) Awards 2012, which recognizes and celebrates the leaders, innovators and pioneers in the vaccines industry.

More... »

INC Research appoints Gaenzle as general counsel

Wednesday, April 11, 2012 03:38 PM

INC Research, a therapeutically focused CRO of Raleigh, N.C., has appointed Christopher L. Gaenzle as its general counsel.  

More... »

Mymetics ropes in Dendreon vets

Wednesday, April 11, 2012 12:58 PM

Mymetics, a Swiss-based biotech of mucosal and virosomal-based vaccines for infectious diseases, has appointed Grant E. Pickering as president and CEO and Christopher S. Henney as chairman of the board of directors. The changes were made in connection with Mymetics’ efforts to obtain additional financing and to advance the development of its vaccine platform.

More... »

Adventrx establishes regulatory advisory board

Monday, April 9, 2012 03:47 PM

San Diego-based Adventrx Pharmaceuticals has established a regulatory advisory board, which will provide drug development and regulatory affairs guidance on the company’s interactions with the FDA.

More... »

Hawkins recieves Outstanding Investigator Award from AFMR

Monday, April 9, 2012 03:08 PM

American Federation for Medical Research (AFMR) has awarded its highest honor for medical research, the Outstanding Investigator Award, to Meredith Hawkins, M.D., professor of medicine and director of the Global Diabetes Initiative at Albert Einstein College of Medicine of Yeshiva University.

More... »

Rosenberg joins Esperion Therapeutics as CMO

Monday, April 9, 2012 02:56 PM

Esperion Therapeutics, a Plythmouth, Michigan-based company that discovers and develops novel therapies for the treatment of cardiovascular and metabolic diseases, has appointed Noah Rosenberg, MD, as its chief medical officer.

More... »

Syndax appoints Pappas to board of directors

Friday, April 6, 2012 03:26 PM

Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company based in Waltham, Mass., has added Arthur M. Pappas to the ranks of its board of directors.

More... »

Eric Abadie resigns as chair of CHMP

Wednesday, April 4, 2012 03:33 PM

Dr. Eric Abadie has resigned from his position as chair of the Committee for Medicinal Products for Human Use (CHMP), according to the European Medicines Agency.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs